TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Noevir Holdings Co., Ltd. ( (JP:4928) ).
Noevir Holdings Co., Ltd. has announced changes in the leadership of its subsidiaries, Noevir Co., Ltd. and TOKIWA Pharmaceutical Co., Ltd., as part of a management restructuring. These changes, which will be finalized at upcoming shareholder and board meetings, aim to streamline operations and enhance strategic focus across various divisions, potentially impacting the company’s market positioning and stakeholder interests.
The most recent analyst rating on (JP:4928) stock is a Buy with a Yen4823.00 price target. To see the full list of analyst forecasts on Noevir Holdings Co., Ltd. stock, see the JP:4928 Stock Forecast page.
More about Noevir Holdings Co., Ltd.
Noevir Holdings Co., Ltd. operates in the cosmetics and pharmaceuticals industry, focusing on beauty and healthcare products. The company is listed on the Tokyo Stock Exchange and is known for its innovative research and development in cosmetics and health-related products.
Average Trading Volume: 121,303
Technical Sentiment Signal: Hold
Current Market Cap: Yen150.6B
See more data about 4928 stock on TipRanks’ Stock Analysis page.